Skip to Content

Expiration Date Looming for Millions of J&J COVID-19 Vaccine Doses

WEDNESDAY, June 9, 2021 -- U.S. federal and state health officials are trying to administer as many doses as possible of the Johnson & Johnson COVID-19 vaccine as millions of unused shots are set to expire this month.

One reason for the large cache of unused doses is the temporary pause in use of the vaccine in April due to concerns about a rare, severe type of blood clot, The Washington Post reported.

Research into extending the shelf life of the one-dose vaccine is ongoing, according to a Johnson & Johnson official, The Post reported. Currently, it can be refrigerated for three months.

Federal health officials are also trying to find ways to extend the life of the doses and are encouraging governors to consult with the U.S. Food and Drug Administration about proper storage, White House coronavirus adviser Andy Slavitt said at a news conference Tuesday, The Post reported.

However, Slavitt conceded that some of the hundreds of millions of doses that have been distributed in the United States will go unused. "There is a very, very small fraction of doses that have been sent out to states that will ultimately not be used," he said.

The Washington Post Article

© 2021 HealthDay. All rights reserved.

Read this next

Risk for Adverse Events Not Increased After COVID-19 Vaccine in IBD

MONDAY, June 14, 2021 -- Individuals with inflammatory bowel disease (IBD) do not have an increased risk for adverse events (AEs) after the mRNA COVID-19 vaccination, according to...

Convalescent Plasma Use Inversely Linked to COVID-19 Mortality

MONDAY, June 14, 2021 -- There is a strong inverse correlation between convalescent plasma (CCP) use per admission and mortality for hospitalized COVID-19 patients, according to a...

Stroke Features Characterized for SARS-CoV-2-Infected Patients

MONDAY, June 14, 2021 -- Rates of severe stroke and stroke in younger patients are higher for stroke patients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.